‌

US Patent 8309300 Cysteine engineered antibodies and conjugates

Patent 8309300 was granted and assigned to Genentech on November, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

Genentech

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8309300

Date of Patent

November 13, 2012

Patent Application Number

12427649

Date Filed

April 21, 2009

Patent Citations Received

‌

US Patent 12129306 Antibodies binding to STEAP-1

‌

US Patent 11999801 Multispecific antibodies

‌

US Patent 12016842 Methods of using anti-CD79b immunoconjugates

‌

US Patent 12018117 Polymer dye modification and applications

‌

US Patent 11834551 Photoactive macromolecules and uses thereof

‌

US Patent 11866496 Humanized anti-CD79B antibodies and immunoconjugates and methods of use

‌

US Patent 11873330 Cysteine engineered antibodies and conjugates

‌

US Patent 11987632 Antibodies binding to HLA-A2/MAGE-A4

...

Patent Primary Examiner

‌

Laura B Goddard

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8309300 Cysteine engineered antibodies and conjugates

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API